The authors reviewed the long-term outcome of focal resection in a large group of patients who had intractable partial nonlesional epilepsy, including mesial temporal lobe sclerosis (MTS), and who were treated consecutively at a single institution. The goal of this study was to evaluate the long-term efficacy of epilepsy surgery and the preoperative factors associated with seizure outcome.
This retrospective analysis included 399 consecutive patients who underwent epilepsy surgery at Mayo Clinic in Rochester, Minnesota, between 1988 and 1996. The mean age of the patients at surgery was 32 ± 12 years (range 3–69 years), and the mean age at seizure onset was 12 ± 11 years (range 0–55 years). There were 214 female (54%) and 185 male (46%) patients. The mean duration of epilepsy was 20 ±12 years (range 1–56 years). The preceding values are given as the mean ± standard deviation.
Of the 399 patients, 237 (59%) had a history of complex partial seizures, 119 (30%) had generalized seizures, 26 (6%) had simple partial seizures, and 17 (4%) had experienced a combination of these. Preoperative evaluation included a routine and video-electroencephalography recordings, magnetic resonance imaging of the head according to the seizure protocol, neuropsychological testing, and a sodium amobarbital study. Patients with an undefined epileptogenic focus and discordant preoperative studies underwent an intracranial study. The mean duration of follow up was 6.2 ± 4.5 years (range 0.6–15.7 years). Seizure outcome was categorized based on the modified Engel classification. Time-to-event analysis was performed using Kaplan–Meier curves and Cox regression models to evaluate the risk factors associated with outcomes.
Among these patients, 372 (93%) underwent temporal and 27 (7%) had extratemporal resection of their epileptogenic focus. Histopathological examination of the resected specimens revealed MTS in 113 patients (28%), gliosis in 237 (59%), and normal findings in 49 (12%). Based on the Kaplan–Meier analysis, the probability of an Engel Class I outcome (seizure free, auras, or seizures related only to medication withdrawal) for the overall patient group was 81% (95% confidence interval [CI] 77–85%) at 6 months, 78% (CI 74–82%) at 1 year, 76% (CI 72–80%) at 2 years, 74% (CI 69–78%) at 5 years, and 72% (CI 67–77%) at 10 years postoperatively. The rate of Class I outcomes remained 72% for 73 patients with more than 10 years of follow up. If a patient was in Class I at 1 year postoperatively, the probability of seizure remission at 10 years postoperatively was 92% (95% CI 89–96%); almost all seizures occurred during the 1st year after surgery. Factors predictive of poor outcome from surgery were normal pathological findings in resected tissue (p = 0.038), male sex (p = 0.035), previous surgery (p < 0.001), and an extratemporal origin of seizures (p < 0.001).
The response to epilepsy surgery during the 1st follow-up year is a reliable indicator of the long-term Engel Class I postoperative outcome. This finding may have important implications for patient counseling and postoperative discontinuation of anticonvulsant medications.
Abbreviations used in this paper: AED = antiepileptic drug; ATL = anterior temporal lobectomy; CI = confidence interval; EEG = electroencephalography; MR = magnetic resonance; MTS = mesial temporal lobe sclerosis; SD = standard deviation; SISCOM = subtracted ictal–interictal SPECT coregistered to MR imaging; SPECT = single-photon emission computerized tomography.
Address reprint requests to: Aaron A. Cohen-Gadol, M.D., Department of Neurologic Surgery, Joseph 1-229, Saint Mary’s Hospital, 1216 Second Street SW, Rochester, Minnesota 55902. email:
CascinoGDTrenerryMRSharbroughFWSoELMarshWRStrelowDC: Depth electrode studies in temporal lobe epilepsy: relation to quantitative magnetic resonance imaging and operative outcome. Epilepsia36:230–2351995
CukiertABuratiniJAMachadoESousaAVieiraJOArgentoniM: Results of surgery in patients with refractory extratemporal epilepsy with normal or nonlocalizing magnetic resonance findings investigated with subdural grids. Epilepsia42:889–8942001
FishDRSmithSJQuesneyLFAndermannFRasmussenT: Surgical treatment of children with medically intractable frontal or temporal lobe epilepsy: results and highlights of 40 years’ experience. Epilepsia34:244–2471993
GarciaPALaxerKDBarbaroNMDillonWP: Prognostic value of qualitative magnetic resonance imaging hippocampal abnormalities in patients undergoing temporal lobectomy for medically refractory seizures. Epilepsia35:520–5241994
GoldsteinRHarveyASDuchownyMJayakarPAltmanNResnickT: Preoperative clinical, EEG, and imaging findings do not predict seizure outcome following temporal lobectomy in childhood. J Child Neurol11:445–4501996
HennessyMJElwesRDHonavarMRabe-HeskethSBinnieCDPolkeyCE: Predictors of outcome and pathological considerations in the surgical treatment of intractable epilepsy associated with temporal lobe lesions. J Neurol Neurosurg Psychiatry70:450–4582001
KilpatrickCCookMMatkovicZO’BrienTKayeAMurphyM: Seizure frequency and duration of epilepsy are not risk factors for postoperative seizure outcome in patients with hippocampal sclerosis. Epilepsia40:899–9031999
O’BrienTJO’ConnorMKMullanBPBrinkmannBHHansonDJackCR: Subtraction ictal SPECT co-registered to MRI in partial epilepsy: description and technical validation of the method with phantom and patient studies. Nucl Med Commun19:31–451998
SchmidtDBaumgartnerCLoscherW: Seizure recurrence after planned discontinuation of antiepileptic drugs in seizure-free patients after epilepsy surgery: a review of current clinical experience. Epilepsia45:179–1862004
WassCTRajalaMMHughesJMSharbroughFWOffordKPRademacherDM: Long-term follow-up of patients treated surgically for medically intractable epilepsy: results in 291 patients treated at Mayo Clinic Rochester between July 1972 and March 1985. Mayo Clin Proc71:1105–11131996
WilliamsonPDFrenchJAThadaniVMKimJHNovellyRASpencerSS: Characteristics of medial temporal lobe epilepsy: II. Interictal and ictal scalp electroencephalography, neuropsychological testing, neuroimaging, surgical results, and pathology. Ann Neurol34:781–7871993